Join us for an exclusive conversation with John Lai, CEO of PetVivo Holdings, Inc. (NASDAQ: PETV), as we explore how this biomedical device company is positioning itself at the intersection of veterinary therapeutics and the explosive AI-driven preventive pet care revolution.

What You'll Discover:

• How Spryng, PetVivo's intra-articular injection for managing lameness and osteoarthritis in dogs and horses, is penetrating the veterinary clinic market
• The strategic significance of the Digital Landia partnership and what AgenticPet's viral adoption (1,000+ beta users in under 72 hours) means for PetVivo's distribution strategy
• Why the shift from reactiv ...